pI: 4.3263 |
Length (AA): 144 |
MW (Da): 16145 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
NA% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_127345)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G04630 | DNA-directed RNA polymerases II and V subunit 6B |
Arabidopsis thaliana | AT5G51940 | RNA polymerase Rpb6 |
Babesia bovis | BBOV_II001260 | DNA-directed RNA polymerase subunit I, putative |
Brugia malayi | Bm1_49350 | DNA-directed RNA polymerases I, II, and III 14.4 kDa polypeptide |
Candida albicans | CaO19.10166 | similar to S. cerevisiae RPO26 (YPR187W) subunit common to RNA polymerase I, II and III |
Candida albicans | CaO19.2643 | similar to S. cerevisiae RPO26 (YPR187W) subunit common to RNA polymerase I, II and III |
Caenorhabditis elegans | CELE_C06A1.5 | Protein RPB-6 |
Cryptosporidium hominis | Chro.70529 | DNA-directed RNA polymerase IIa |
Cryptosporidium parvum | cgd7_4770 | DNA-directed RNA polymerase subunit |
Dictyostelium discoideum | DDB_G0291037 | RNA polymerase I core subunit |
Drosophila melanogaster | Dmel_CG1163 | RNA polymerase II 18kD subunit |
Echinococcus granulosus | EgrG_000230200 | dna directed rna polymerases i ii and iii |
Entamoeba histolytica | EHI_088230 | DNA-directed RNA polymerases I, II, and III 23 kDa, putative |
Echinococcus multilocularis | EmuJ_000230200 | DNA directed RNA polymerases I, II, and III |
Giardia lamblia | GL50803_15955 | DNA-directed RNA polymerase II RPB6 |
Homo sapiens | ENSG00000100142 | polymerase (RNA) II (DNA directed) polypeptide F |
Leishmania braziliensis | LbrM.20.0860 | DNA-directed RNA polymerase subunit, putative |
Leishmania donovani | LdBPK_340940.1 | DNA-directed RNA polymerase subunit, putative |
Leishmania infantum | LinJ.34.0940 | DNA-directed RNA polymerase subunit, putative |
Leishmania major | LmjF.34.0890 | DNA-directed RNA polymerase subunit, putative |
Leishmania mexicana | LmxM.33.0890 | DNA-directed RNA polymerase subunit, putative |
Loa Loa (eye worm) | LOAG_10547 | hypothetical protein |
Mus musculus | ENSMUSG00000033020 | polymerase (RNA) II (DNA directed) polypeptide F |
Neospora caninum | NCLIV_036000 | Polymerase (RNA) II (DNA directed) polypeptide F, related |
Oryza sativa | 4343168 | Os07g0463100 |
Oryza sativa | 4333343 | Os03g0586600 |
Plasmodium berghei | PBANKA_0401900 | DNA-directed RNA polymerases I, II, and III subunit RPABC2, putative |
Plasmodium falciparum | PF3D7_0303300 | DNA-directed RNA polymerases I, II, and III subunit RPABC2, putative |
Plasmodium knowlesi | PKNH_0839800 | DNA-directed RNA polymerases I, II, and III subunit RPABC2, putative |
Plasmodium vivax | PVX_119290 | DNA-directed RNA polymerases I, II, and III 14.4 kDa polypeptide, putative |
Plasmodium yoelii | PY01352 | Plasmodium vivax PV1H14085_P |
Saccharomyces cerevisiae | YPR187W | DNA-directed RNA polymerase core subunit RPB6 |
Schistosoma japonicum | Sjp_0071940 | ko:K03014 DNA-directed RNA Polymerase II subunit F, putative |
Schistosoma mansoni | Smp_073570 | DNA-directed rna polymerase subunit rpb6 |
Schmidtea mediterranea | mk4.007711.01 | DNA-directed RNA polymerases I, II, and III subunit RPABC2 |
Schmidtea mediterranea | mk4.013887.00 | DNA-directed RNA polymerases I, II, and III subunit RPABC2 |
Schmidtea mediterranea | mk4.002671.04 | DNA-directed RNA polymerases I, II, and III subunit RPABC2 |
Trypanosoma brucei gambiense | Tbg972.4.3500 | DNA-directed RNA polymerase subunit, putative |
Trypanosoma brucei gambiense | Tbg972.4.3515 | DNA-directed RNA polymerase subunit, putative |
Trypanosoma brucei | Tb927.4.3490 | DNA-directed RNA polymerases II and III subunit RPB6, putative |
Trypanosoma brucei | Tb927.4.3510 | DNA-directed RNA polymerase subunit, putative |
Trypanosoma cruzi | TcCLB.506199.5 | DNA-directed RNA polymerase subunit, putative |
Trypanosoma cruzi | TcCLB.507159.90 | DNA-directed rna polymerase II subunit, putative |
Trypanosoma cruzi | TcCLB.507485.15 | DNA-directed RNA polymerase subunit, putative |
Trypanosoma cruzi | TcCLB.507159.44 | DNA-directed rna polymerase II subunit, putative |
Trypanosoma cruzi | TcCLB.507673.65 | DNA-directed RNA polymerase subunit, putative |
Trypanosoma cruzi | TcCLB.507159.65 | DNA-directed RNA polymerase subunit, putative |
Trypanosoma cruzi | TcCLB.507485.34 | DNA-directed RNA polymerase III subunit, putative |
Toxoplasma gondii | TGME49_270780 | DNA-directed RNA polymerase II RPB6 |
Trichomonas vaginalis | TVAG_221960 | DNA-directed RNA polymerase subunit rpb6, putative |
Trichomonas vaginalis | TVAG_348020 | DNA-directed RNA polymerase subunit rpb6, putative |
Trichomonas vaginalis | TVAG_352310 | DNA-directed RNA polymerase subunit rpb6, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.4.3490 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.4.3490 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.4.3490 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.4.3490 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C06A1.5 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C06A1.5 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C06A1.5 | Caenorhabditis elegans | sterile | wormbase |
YPR187W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_0401900 | Plasmodium berghei | Essential | plasmo |
TGME49_270780 | Toxoplasma gondii | Probably essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 3 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
49 literature references were collected for this gene.